Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID

Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736  Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor…[...]

Read More

Long COVID clinical evaluation, research and impact on society: a global expert consensus

Andrew G. Ewing, David Joffe, Svetlana Blitshteyn, et. al., Annals of Clinical Microbiology and Antimicrobials volume 24, Article number: 27 (2025)  Abstract Background Long COVID is a complex, heterogeneous syndrome affecting over four hundred million people globally. There…[...]

Read More